Is Beyond Air, Inc. overvalued or undervalued?

As of 24 June 2024, the valuation grade for Beyond Air, Inc. has moved from does not qualify to risky. The company appears to be overvalued based on its current metrics. Key ratios include a Price to Book Value of 0.93, an EV to EBIT of -0.29, and an EV to EBITDA of -0.31, all indicating significant financial distress and inefficiency.
In comparison to peers, Beyond Air, Inc. has a less favorable EV to EBITDA ratio than Perspective Therapeutics, Inc. at -0.7951 and a stark contrast to Electromed, Inc., which has a fair valuation with an EV to EBITDA of 17.5033. The company's stock has underperformed significantly, with a year-to-date return of -68.06% compared to the S&P 500's gain of 12.22%, highlighting its struggles in the market.